Therapeutic potential of carbon dots from Lycium barbarum in radiation-induced bone injury
Deepak Kumar Khajuria,David Karasik
DOI: https://doi.org/10.21037/atm-24-10
IF: 3.616
2024-06-06
Annals of Translational Medicine
Abstract:Deepak Kumar Khajuria 1,2 , David Karasik 3 1 Department of Orthopaedics and Rehabilitation, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA; 2 Center for Orthopaedic Research and Translational Science (CORTS), The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA; 3 The Musculoskeletal Genetics Laboratory, The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel Comment on: Guo Z, Wang Z, Liu Y, et al . Carbon Dots from Lycium barbarum Attenuate Radiation-Induced Bone Injury by Inhibiting Senescence via METTL3/Clip3 in an m6A-Dependent Manner. ACS Appl Mater Interfaces 2023;15:20726-41. Keywords: Carbon dots (CDs); osteoradionecrosis (ORN); osseointegration; RNA; senescence Submitted Jan 21, 2024. Accepted for publication May 16, 2024. Published online May 30, 2024. doi: 10.21037/atm-24-10 It would be a challenge to place this paper into one specific category; it encompasses a lot for one article, by providing a glimpse into a variety of topics, all interconnected but diverse. Even having a quite large supplemental material still requires from a reader—who might be a bioengineer or biochemistry major—to dig into the carbon dots (CDs) and RNA methylomics, and from a clinical scientist—to refresh their molecular knowledge (and insight into the herbal medicine!). We consider this to be a plus for any scientific publication to both enlighten the reader in the new findings as well as to make them wish to learn/read more. What is certain, this report is a must-read for a bone-centered biologist. Here we review this demanding article having mostly this type of audience in mind. Radiotherapy alone or in combination with chemotherapy has been proven successful in cancer patients. As survival rates rise, the collateral consequences of radiation therapy become prominent; these include bone deterioration which leads to a wide range of skeletal abnormalities, including osteoradionecrosis (ORN) and pathological (low energy) fractures (1,2). Significant patient morbidity and increased mortality can thus arise from cancer treatment-related radiation and radiation-induced ORN (2,3). Conservative management of ORN includes local irrigation, systemic antibiotics, and hyperbaric oxygen therapy (3,4). ORN is akin to osteonecrosis of the jaw because of bisphosphonate treatment. For the advanced stage of ORN, the radical excision of the jaw with repair using a microvascular osteomyocutaneous free flap is crucial (5). Nevertheless, up to 43% of surgical procedures result in complications (6). Specifically for the jaws and dental implants, radiation therapy induces ORN and therefore significantly reduces the longevity of implants (7,8). Bottom line, at present there is no effective treatment for radiation-induced bone injury. In a research article, Guo and colleagues (9) report an important translational study on the potential therapeutic effect of CDs synthesized from Lycium barbarum against radiation-induced bone injury in a rat model of ORN. The group of the co-authors are all affiliated with the Department of Oromaxillofacial, Head & Neck Oncology and College of Stomatology, which explains its focus on mainly jaw bones. The main translational outcomes of this study are that CDs alleviated radiation-induced bone injury and stimulated osteogenesis surrounding titanium implants (9). CDs are innovative nanoparticles with stable physicochemical properties and good biocompatibility that are receiving a lot of attention in biomedical applications (10,11). CDs have been shown to increase osteogenic activity (12). Shao and colleagues reported both tracking and the osteogenic potential of citric acid-based CDs in rat bone marrow mesenchymal stem cells (BMSCs). The authors demonstrated that the presence of CDs effectively facilitated osteogenic differentiation of the BMSCs via ROS-mediated MAPK pathway (13). Jin and colleagues reported ascorbic acid CDs which promote osteoblasts differentiation by activation of endoplasmic reticulum stress and PERK-eIF2α-ATF4 pathway by inducing calcium leakage in the endoplasmic reticulum of osteoblasts (14). Wan and colleagues reported dexamethasone CDs that can stimulate the bone immune microenvironment and further accelerate the differentiation of BMSCs to facilitate bone tissue healing (15). We conducted one study in our Musculoskeletal Genetics Laboratory where zebrafish were treated with nitrogen-doped CDs functionalized with hydroxyapatite nanoparticles (NCDs-HA) for up to 35 days after jaw resection surgery (16). Our findings demonstrated that NCDs-HA nanoparticles induced MC3T3-E1 osteoblast line differentiation and proliferation; ensuing micro-CT (μCT) analyses affirmed the ability of NCDs-HA nanoparticles to accelerate regeneration in a z -Abstract Truncated-
oncology,medicine, research & experimental